Literature DB >> 2644625

Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.

M H Lai1, D R Kirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2644625      PMCID： PMC331629          DOI： 10.1093/nar/17.2.804

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  Fungal infection and fever of unknown origin in neutropenic patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-05-30       Impact factor: 4.965

2.  Isolation of the gene for cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.

Authors:  D R Kirsch; M H Lai; J O'Sullivan
Journal:  Gene       Date:  1988-09-07       Impact factor: 3.688

3.  Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae.

Authors:  V F Kalb; C W Woods; T G Turi; C R Dey; T R Sutter; J C Loper
Journal:  DNA       Date:  1987-12
  3 in total
  34 in total

1.  Tandem repeat of a transcriptional enhancer upstream of the sterol 14alpha-demethylase gene (CYP51) in Penicillium digitatum.

Authors:  H Hamamoto; K Hasegawa; R Nakaune; Y J Lee; Y Makizumi; K Akutsu; T Hibi
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

2.  Transcriptional analyses of antifungal drug resistance in Candida albicans.

Authors:  C N Lyons; T C White
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450.

Authors:  K Asai; N Tsuchimori; K Okonogi; J R Perfect; O Gotoh; Y Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Codon utilisation in the pathogenic yeast, Candida albicans.

Authors:  A J Brown; G Bertram; P J Feldmann; M W Peggie; R K Swoboda
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

5.  Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis.

Authors:  G Morace; M Sanguinetti; B Posteraro; G Lo Cascio; G Fadda
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.

Authors:  D Talibi; M Raymond
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

7.  Purification and properties of cytochrome P-450-dependent 14 alpha-sterol demethylase from Candida albicans.

Authors:  C A Hitchcock; K Dickinson; S B Brown; E G Evans; D J Adams
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

Review 8.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

9.  Induction and substrate specificity of the lanosterol 14 alpha-demethylase from Saccharomyces cerevisiae Y222.

Authors:  G D Wright; J F Honek
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

10.  Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Authors:  J L Lopez-Ribot; R K McAtee; L N Lee; W R Kirkpatrick; T C White; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.